Simris Group AB Logo

Simris Group AB

Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.

SIMRIS | ST

Overview

Corporate Details

ISIN(s):
SE0008091656 (+1 more)
LEI:
529900P0ACIS2UI3ZX27
Country:
Sweden
Address:
Herrestadsvägen 24A, 276 50 HAMMENHÖG
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Simris Group AB is a biotechnology company specializing in the development of next-generation payloads for Antibody-Drug Conjugates (ADCs) to advance cancer treatment. The company leverages its proprietary platform, which is built upon the world's largest cyanobacterial strain library and deep expertise in bioconjugation technologies. Simris engineers and develops novel, IP-protected payloads using cyanobacterial toxin engineering. These payloads are designed to improve the therapeutic window of ADCs by enhancing their potency, safety, and selectivity compared to conventional options, with the goal of revolutionizing the therapeutic potential of ADC treatments in oncology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Simris Group AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Simris Group AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel HRON
HVIVO PLC Logo
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom HVO
Iconovo AB Logo
Develops inhaled therapies and patented dry powder inhalers for global pharma partners.
Sweden ICO
IMMUPHARMA PLC Logo
Develops novel peptide therapeutics for autoimmune diseases like Lupus (SLE) and CIDP.
United Kingdom IMM
Inhalation Sciences Sweden AB Logo
Inhalation research instruments and CRO services for preclinical pharma/biotech development.
Sweden ISAB
Initiator Pharma A/S Logo
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark INIT
IXICO PLC Logo
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom IXI
J. Molner AS Logo
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia JML
LYSOGENE Logo France LYS
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.